[1]
Cavalletto, L. et al. 2008. Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice. Farmeconomia. Health economics and therapeutic pathways. 9, 4 (Jan. 2008), 173–181. DOI:https://doi.org/10.7175/fe.v9i4.235.